May 2015 Recap of Drug Updates

The summary below gives an overview of some of the important additions and changes MPR has made to its drug database through the end of May. The chart below provides highlights of the 126 key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME
 UPDATES
(Click on drug name to go to MPR monograph.)  D IND ITX CI W/P ADR HS MFR
ATRIPLA (Efavirenz, emtricitabine, tenofovir disoproxil fumarate) X X
AVELOX (Moxifloxacin) X X
CARDIZEM CD (Diltiazem HCI) X X X
CLOZARIL (Clozapine) X X X
CRIXIVAN (Indinavir) X X X X X
DIOVAN (Valsartan) X
ISORDIL TITRADOSE (Isosorbide dinitrate) X X X X X
LOPID (Gemfibrozil) X X
PAXIL (Paroxetine) X X X
PEGASYS (Peginterferon alfa-2a) X X X X
TOFRANIL (Imipramine HCl) X X X X
ZOFRAN (Ondansetron) X X



Review more drug monograph updates



Loading links....